Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

Pallas Health vs Start Willow: Clinician Choice vs Fast Shipping

Pallas Health vs Start Willow: quick verdict. Pallas Health combines clinician choice between FDA-approved brand-name GLP-1 and compounded options and starts compounded semaglutide at $139 for the first month, then $597 every 12 weeks (a $199/month average). Start Willow offers only compounded semaglutide from $249 per month and commits to delivery in 3 days or less. Choose Pallas for brand options and clinician selection; choose Start Willow for a fast, direct-pay shipping promise.

Start Pallas Health intake

Pallas Health vs Start Willow: key differences at a glance

The most distinctive differences are pricing structure and intro rates, availability of FDA-approved brand-name pens, delivery speed commitments, and the platforms’ approach to insurance and membership. Below we compare those points directly using only the supplied facts.

Pricing and ongoing cost

Pallas Health lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks, which the provider reports as a $199 per month average. Compounded tirzepatide is $179 first month then $897 every 12 weeks ($299/month average). Pallas also lists cash-pay pricing for brand-name Wegovy, Ozempic, Zepbound and Mounjaro as monthly cash prices on the site. Start Willow quotes compounded semaglutide from $249 per month, with a disclosed ongoing rate rising to $299/month. Start Willow notes the $299 ongoing rate is among the higher rates on the list.

Start Willow order flow

Brand-name availability and medication options

Pallas Health supports both routes from one intake: FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro or clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Start Willow provides compounded medications comparable to Ozempic and tirzepatide; its offering is compounded semaglutide as part of a personalized treatment plan and does not offer branded finished products. Both sources note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Shipping speed and fulfillment commitments

Start Willow guarantees delivery in 3 days or less and references same-day prescriptions and free 2-Day shipping from its in-stock items, highlighting fast fulfillment as a core feature. Pallas Health offers free expedited shipping on every plan but does not supply the same specific multi-day delivery guarantee in the supplied evidence. Both use licensed pharmacies for dispensing and shipping.

Insurance, membership and clinician review

Both platforms operate without requiring insurance and charge no membership fees in the supplied evidence. Start Willow emphasizes a direct-pay model that bypasses insurance pre-authorization and is positioned for patients frustrated by those denials. Pallas Health is cash-pay only and does not bill insurance; it notes that treatment may be FSA or HSA eligible with a Letter of Medical Necessity requested during intake. Pallas further emphasizes that eligibility and medication selection are determined by a US-licensed clinician and that provider care, check-ins and messaging are included in its all-in plan price.

Get Pallas clinician review

Direct comparison table

Criteria Pallas Health Start Willow
Starting price $139 first month for compounded semaglutide From $249 per month
Ongoing price $597 every 12 weeks; $199/mo average for semaglutide $299/month ongoing
Brand-name availability Offers FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro plus compounded options Compounded alternatives only, comparable to Ozempic and tirzepatide
Shipping promise Free expedited shipping on every plan Delivery guaranteed in 3 days or less; same-day prescriptions and free 2-Day shipping noted
Insurance and fees Cash-pay only, no membership fee; may be FSA/HSA eligible with Letter of Medical Necessity No insurance needed, no membership fees; direct-pay model
Clinician & care US-licensed clinician personalizes plan; provider care, check-ins and messaging included Licensed clinician prescribes compounded semaglutide as part of a personalized plan

States, visits and service limits

Pallas Health notes it is 100% online and asynchronous in most states, with a video visit required in seven states plus Washington, D.C. Pallas also states care-team hours are weekdays 9 AM to 5 PM ET and no emergency services are offered. Start Willow is presented as fully online with no in-person visits or insurance forms in the supplied evidence; specific state visit requirements are not provided in the Start Willow material here.

Sign up with Pallas Health

How to decide: Choose based on what matters most

Pallas Health vs Start Willow comparison summary: Pallas Health is distinctive for offering both FDA-approved brand-name pens and clinician-personalized compounded options from a single intake, with an all-in plan price that includes provider care and messaging and a low intro compounded month price of $139. Start Willow is distinctive for a straightforward direct-pay, no-membership model with a specific fast shipping promise of delivery in 3 days or less and a starting price of $249, rising to $299/month ongoing.

Choose Pallas Health if you want clinician access to both branded FDA-approved GLP-1 pens and compounded preparations, an all-in plan price with provider care and a lower introductory compounded rate.

Choose Start Willow if you prioritize a direct-pay flow with a 3-day delivery guarantee and a simple compounded-semaglutide offering without insurance or membership steps.

Start Willow checkout

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.